(Q81208645)
Statements
Potent and specific antitumor efficacy of CMC-544, a CD22-targeted immunoconjugate of calicheamicin, against systemically disseminated B-cell lymphoma (English)
John F DiJoseph
Mary E Goad
Maureen M Dougher
Erwin R Boghaert
Arthur Kunz
Philip R Hamann